Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 40.94
+0.94 (2.35%)
Jun 18, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 38.83 billion as of June 18, 2026. Its market cap has increased by 532.12% in one year.
Market Cap
38.83B
Enterprise Value
38.56B
Revenue
1.78B
Ranking
n/a
PE Ratio
49.12
Stock Price
40.94
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 38.83B, an increase of 276.48%. That is a compound annual growth rate of 41.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 41.23B | 74.80% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 82.01B |
| Akeso | 77.28B |
| RemeGen | 58.78B |
| 3SBio | 40.16B |
| Shanghai Henlius Biotech | 32.37B |
| Shanghai Junshi Biosciences | 30.21B |
| Genscript Biotech | 24.66B |
| InnoCare Pharma | 21.72B |